2vci: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2vci.png|left|200px]] | [[Image:2vci.png|left|200px]] | ||
{{STRUCTURE_2vci| PDB=2vci | SCENE= }} | {{STRUCTURE_2vci| PDB=2vci | SCENE= }} | ||
===4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER=== | ===4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER=== | ||
{{ABSTRACT_PUBMED_18020435}} | {{ABSTRACT_PUBMED_18020435}} | ||
==About this Structure== | ==About this Structure== | ||
[[2vci]] is a 1 chain structure of [[Heat Shock Proteins]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VCI OCA]. | |||
==See Also== | |||
*[[Heat Shock Proteins|Heat Shock Proteins]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:018020435</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Aherne, W.]] | [[Category: Aherne, W.]] | ||
| Line 62: | Line 53: | ||
[[Category: Workman, P.]] | [[Category: Workman, P.]] | ||
[[Category: Wright, L.]] | [[Category: Wright, L.]] | ||
[[Category: Atp-binding]] | [[Category: Atp-binding]] | ||
[[Category: Chaperone]] | [[Category: Chaperone]] | ||
[[Category: Nucleotide-binding]] | [[Category: Nucleotide-binding]] | ||
[[Category: Phosphorylation]] | [[Category: Phosphorylation]] | ||
[[Category: Stress response]] | [[Category: Stress response]] | ||
Revision as of 02:21, 27 July 2012
4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
Template:ABSTRACT PUBMED 18020435
About this Structure
2vci is a 1 chain structure of Heat Shock Proteins with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Brough PA, Aherne W, Barril X, Borgognoni J, Boxall K, Cansfield JE, Cheung KM, Collins I, Davies NG, Drysdale MJ, Dymock B, Eccles SA, Finch H, Fink A, Hayes A, Howes R, Hubbard RE, James K, Jordan AM, Lockie A, Martins V, Massey A, Matthews TP, McDonald E, Northfield CJ, Pearl LH, Prodromou C, Ray S, Raynaud FI, Roughley SD, Sharp SY, Surgenor A, Walmsley DL, Webb P, Wood M, Workman P, Wright L. 4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer. J Med Chem. 2008 Jan 24;51(2):196-218. Epub 2007 Nov 20. PMID:18020435 doi:10.1021/jm701018h
Proteopedia Page Contributors and Editors (what is this?)
Categories:
- Pages with broken file links
- Homo sapiens
- Aherne, W.
- Barril, X.
- Borgognoni, J.
- Boxal, K.
- Brough, P A.
- Cansfield, J E.
- Cheung, K M.
- Collins, I.
- Davies, N G.M.
- Drysdale, M J.
- Dymock, B.
- Eccles, S A.
- Finch, H.
- Fink, A.
- Hayes, A.
- Howes, R.
- Hubbard, R E.
- James, K.
- Jordan, A M.
- Lockie, A.
- Martins, V.
- Massey, A.
- Matthews, T P.
- Mcdonald, E.
- Northfield, C J.
- Pearl, L H.
- Prodromou, C.
- Ray, S.
- Raynaud, F I.
- Roughley, S D.
- Sharp, S Y.
- Surgenor, A.
- Walmsley, D L.
- Webb, P.
- Wood, M.
- Workman, P.
- Wright, L.
- Atp-binding
- Chaperone
- Nucleotide-binding
- Phosphorylation
- Stress response